<DOC>
	<DOCNO>NCT00707759</DOCNO>
	<brief_summary>The present study investigate safety efficacy steroid withdrawal six day post-transplant pediatric renal recipient concomitant immunosuppression base antibody anti IL2 ( interleukin 2 ) , Tacrolimus ( TAC ) Mycophenolate Mofetil ( MMF ) . To investigate impact protocol growth , bone metabolism , insulin- sensitivity evaluate expression IL17 ( interleukin 17 ) mRNA FOXP3 ( messenger ribonucleic acid forkhead box protein 3 ) early marker acute rejection ( blood , urine renal biopsy ) . Hypothesis : Steroid withdrawal renal pediatric transplant patient improve growth bone metabolism without increase risk acute rejection . The expression FoxP3/IL17 urine cell could early molecular marker acute rejection .</brief_summary>
	<brief_title>Steroid Withdrawal Pediatric Renal Transplant : Impact Growth , Bone Metabolism Acute Rejection</brief_title>
	<detailed_description>The intention investigation evaluate prospective immunosuppressive protocol base antibody anti IL-2 ( Ac-IL-2 ) , Tacrolimus ( TAC ) Mycophenolate Mofetil ( MMF ) withdrawal steroid renal transplant compare steroid-based protocol . Objectives : 1 . To evaluate growth impairment GH/IGF ( growth hormone/insulin like growth factor ) axis 2 . To determine impact steroid bone metabolism ( biochemical parameter , DXA pQCT ) 3 . To determine steroid effect metabolic factor ( dyslipidemia , insulin- sensitivity arterial hypertension ) 4 . To determine acute rejection incidence ( protocol renal biopsy ) 5 . To evaluate expression IL-17 mRNA FoxP3 early marker acute rejection ( blood , urine renal biopsy ) . Two treatment regime ( Arms ) compare randomized form course 12 month transplantation . Arm A : TAC + MMF + withdrawal steroid six-days follow randomization . Arm B : TAC + MMF + prednisolone ( see schedule ) /day</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Prednisolone acetate</mesh_term>
	<mesh_term>Methylprednisolone acetate</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Prednisolone</mesh_term>
	<mesh_term>Methylprednisolone</mesh_term>
	<mesh_term>Methylprednisolone Hemisuccinate</mesh_term>
	<mesh_term>Prednisolone hemisuccinate</mesh_term>
	<mesh_term>Prednisolone phosphate</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<criteria>Age &lt; 16.0 year Bone age boys &lt; 15 year , girl &lt; 13 year Prepuberal Tanner Status I First second kidney transplant , live decease kidney donation Immunosuppression Tacrolimus ( TAC ) , Mycophenolate mofetil ( MMF ) Patients parent , respectively , give write consent enlightenment ( informed consent ) Irreversible rejection former transplant Highly reactive ( &gt; 30 % ) lymphocytotoxic antibody within 12 month prior transplantation Suspected insufficient medication compliance dialysis Patients receive basic immunosuppression prescribe protocol Simultaneous therapy growth hormone renal transplant</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Pediatric renal transplantation , Bone metabolism ( DXA-pQCT )</keyword>
	<keyword>mRNAFOXP3/IL-17 , Steroid withdrawal</keyword>
</DOC>